Jennifer Pietenpol

Vanderbilt University has awarded a new cycle of Innovation Catalyst Fund grants to pioneering faculty projects that advance health care technology, AI tools for research impact and wearable devices. These grants support translational research and drive real-world solutions across disciplines, underscoring Vanderbilt's commitment to fostering innovation and societal impact. Read More

Vanderbilt has announced the February 2024 Innovation Catalyst Fund awardees, propelling groundbreaking research into practical applications. Read More

Vanderbilt University School of Medicine, which received $527.7 million in direct and indirect NIH grant support in FY23, has been among the top 10 U.S. medical schools in NIH funding for six of the last 10 years. Read More

Jennifer Pietenpol, Ingram Professor of Cancer Research and professor of biochemistry, is the 2024 recipient of the Science of Oncology Award, which is presented annually to an individual who has made outstanding contributions to basic or translational research in cancer. Read More

The Vanderbilt Innovation Catalyst Fund honors eight projects in its inaugural pre-seed funding round, showcasing the university’s commitment to transforming research into real-world solutions. Read More

Vanderbilt University's Innovation Catalyst Fund, dedicated to advancing translational research, begins accepting applications Sunday, Oct. 1. This transformative initiative, bridging research, innovation and real-world solutions, invites faculty across all disciplines to submit groundbreaking research proposals by Oct. 31. Read More

The Innovation Catalyst Fund aims to boost translational research and innovation to bridge the gap between ideas and real-world solutions. This initiative seeks to support projects that are nearing commercial viability, fostering innovation across a wide range of academic disciplines. Faculty can register for a Q&A town hall on Sept. 18 before the proposal submission portal opens on Oct. 1. Read More

Nominations are open for the ninth cohort of the Chancellor Faculty Fellows, a program that awards select faculty with financial and institutional support at a key moment in their careers. Learn more and read about past awardees' successes. Read More

John Kuriyan, one of the world’s most esteemed structural biologists, will become dean of Vanderbilt University’s School of Medicine Basic Sciences effective Jan. 1, 2023. Read More

Chancellor Daniel Diermeier lauded Vanderbilt faculty’s accomplishments and deep commitment to radical collaboration in his remarks at the Spring Faculty Assembly on April 28. In addition, six faculty were recognized with some of university’s highest honors. Read More

Faculty at Vanderbilt University and Vanderbilt University Medical Center achieved a significant milestone in 2021: more than $1 billion in research funding awarded from external organizations.  Read More

  by Bill Snyder In a multidisciplinary collaboration, researchers at Vanderbilt University Medical Center and the University of Miami Miller School of Medicine have identified a subtype of triple-negative breast cancer (TNBC) that appears to be able to escape detection by the immune system and evade immunotherapy. Their report, published Nov. 1 in the journal... Read More

The Vanderbilt Institute for Infection, Immunology and Inflammation (VI4) recently moved into its new research and administrative home. Read More

Six cross-disciplinary programs have been awarded funding for 2020 by Vanderbilt’s Trans-Institutional Programs initiative, a hallmark of the university’s Academic Strategic Plan. Read More

Ten outstanding faculty members from across the university have been selected for the 2020 cohort of Chancellor Faculty Fellows. This group is composed of highly accomplished, recently tenured faculty from a wide variety of disciplines and areas of expertise. Read More

As Nashville cautiously begins to emerge from its two-month-long COVID-19 Safer at Home response, so too are the labs and facilities at Vanderbilt University Medical Center. Read More

Researchers from Vanderbilt-Ingram Cancer Center (VICC) discovered a role for MYCN in triple-negative breast cancer (TNBC), a particularly aggressive form of the disease, and identified a potential intervention for further clinical investigation. Read More

Researchers at VUMC are reporting another advance in the understanding and treatment of triple-negative breast cancer, which is particularly aggressive and difficult to treat. Read More

The Office of the Provost is issuing the sixth annual call for proposals for Trans-Institutional Programs, an internal faculty funding program that is a key initiative of the Academic Strategic Plan. Read More

Breast cancer researchers at Vanderbilt-Ingram Cancer Center have secured a fourth round of continuous Specialized Program of Research Excellence funding. Read More